In COVID-19 patients, high levels of IL-6 have been associated with death2, while during SARS-CoV-2 infection until now no alterations have been described in the levels of IL-11, a molecule which is linked to the hyperreactivity of the airways during viral infection. The gene discussed is IL11; the disease is COVID-19.